2-bromo-6-(6-tert-butyl-1-oxo-3,4-dihydro-2,7-naphthyridin-2-yl)benzaldehyde;5-bromo-1-methyl-3-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]pyridin-2-one;6-tert-butyl-3,4-dihydro-2H-2,7-naphthyridin-1-one;6-tert-butyl-4-[2-(1,3-dioxoisoindol-2-yl)ethyl]pyridine-3-carboxamide;6-tert-butyl-2-[2-(hydroxymethyl)-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]phenyl]-3,4-dihydro-2,7-naphthyridin-1-one;2-(6-tert-butyl-1-oxo-3,4-dihydro-2,7-naphthyridin-2-yl)-6-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]benzaldehyde;6-tert-butylpyridine-3-carboxamide;2,6-dibromobenzaldehyde;2,2-dimethylpropanoic acid;3-(1,3-dioxoisoindol-2-yl)propanoic acid;pyridine-3-carboxamide

C176H190Br4N28O28 — CID 159068578

IUPAC2-bromo-6-(6-tert-butyl-1-oxo-3,4-dihydro-2,7-naphthyridin-2-yl)benzaldehyde;5-bromo-1-methyl-3-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]pyridin-2-one;6-tert-butyl-3,4-dihydro-2H-2,7-naphthyridin-1-one;6-tert-butyl-4-[2-(1,3-dioxoisoindol-2-yl)ethyl]pyridine-3-carboxamide;6-tert-butyl-2-[2-(hydroxymethyl)-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]phenyl]-3,4-dihydro-2,7-naphthyridin-1-one;2-(6-tert-butyl-1-oxo-3,4-dihydro-2,7-naphthyridin-2-yl)-6-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]benzaldehyde;6-tert-butylpyridine-3-carboxamide;2,6-dibromobenzaldehyde;2,2-dimethylpropanoic acid;3-(1,3-dioxoisoindol-2-yl)propanoic acid;pyridine-3-carboxamide
SMILESCC(C)(C)C(=O)O.CC(C)(C)c1cc(CCN2C(=O)c3ccccc3C2=O)c(C(N)=O)cn1.CC(C)(C)c1cc2c(cn1)C(=O)N(c1cccc(Br)c1C=O)CC2.CC(C)(C)c1cc2c(cn1)C(=O)NCC2.CC(C)(C)c1ccc(C(N)=O)cn1.Cn1cc(-c2cccc(N3CCc4cc(C(C)(C)C)ncc4C3=O)c2C=O)cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c1=O.Cn1cc(-c2cccc(N3CCc4cc(C(C)(C)C)ncc4C3=O)c2CO)cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c1=O.Cn1cc(Br)cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c1=O.NC(=O)c1cccnc1.O=C(O)CCN1C(=O)c2ccccc2C1=O.O=Cc1c(Br)cccc1Br
InChIInChI=1S/C35H38N6O5.C35H36N6O5.C20H21N3O3.C19H19BrN2O2.C16H17BrN4O3.C12H16N2O.C11H9NO4.C10H14N2O.C7H4Br2O.C6H6N2O.C5H10O2/c2*1-35(2,3)30-17-22-10-11-41(33(44)26(22)19-36-30)29-7-5-6-25(27(29)21-42)24-16-28(34(45)39(4)20-24)38-31-9-8-23(18-37-31)32(43)40-12-14-46-15-13-40;1-20(2,3)16-10-12(15(11-22-16)17(21)24)8-9-23-18(25)13-6-4-5-7-14(13)19(23)26;1-19(2,3)17-9-12-7-8-22(18(24)13(12)10-21-17)16-6-4-5-15(20)14(16)11-23;1-20-10-12(17)8-13(16(20)23)19-14-3-2-11(9-18-14)15(22)21-4-6-24-7-5-21;1-12(2,3)10-6-8-4-5-13-11(15)9(8)7-14-10;13-9(14)5-6-12-10(15)7-3-1-2-4-8(7)11(12)16;1-10(2,3)8-5-4-7(6-12-8)9(11)13;8-6-2-1-3-7(9)5(6)4-10;7-6(9)5-2-1-3-8-4-5;1-5(2,3)4(6)7/h5-9,16-20,42H,10-15,21H2,1-4H3,(H,37,38);5-9,16-21H,10-15H2,1-4H3,(H,37,38);4-7,10-11H,8-9H2,1-3H3,(H2,21,24);4-6,9-11H,7-8H2,1-3H3;2-3,8-10H,4-7H2,1H3,(H,18,19);6-7H,4-5H2,1-3H3,(H,13,15);1-4H,5-6H2,(H,13,14);4-6H,1-3H3,(H2,11,13);1-4H;1-4H,(H2,7,9);1-3H3,(H,6,7)
InChIKeyJZIZCVHWRXXQBW-UHFFFAOYSA-N
MW3465.24 g/mol
LogP24.88
Rot. Bonds27

About 2-bromo-6-(6-tert-butyl-1-oxo-3,4-dihydro-2,7-naphthyridin-2-yl)benzaldehyde;5-bromo-1-methyl-3-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]pyridin-2-one;6-tert-butyl-3,4-dihydro-2H-2,7-naphthyridin-1-one;6-tert-butyl-4-[2-(1,3-dioxoisoindol-2-yl)ethyl]pyridine-3-carboxamide;6-tert-butyl-2-[2-(hydroxymethyl)-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]phenyl]-3,4-dihydro-2,7-naphthyridin-1-one;2-(6-tert-butyl-1-oxo-3,4-dihydro-2,7-naphthyridin-2-yl)-6-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]benzaldehyde;6-tert-butylpyridine-3-carboxamide;2,6-dibromobenzaldehyde;2,2-dimethylpropanoic acid;3-(1,3-dioxoisoindol-2-yl)propanoic acid;pyridine-3-carboxamide

2-bromo-6-(6-tert-butyl-1-oxo-3,4-dihydro-2,7-naphthyridin-2-yl)benzaldehyde;5-bromo-1-methyl-3-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]pyridin-2-one;6-tert-butyl-3,4-dihydro-2H-2,7-naphthyridin-1-one;6-tert-butyl-4-[2-(1,3-dioxoisoindol-2-yl)ethyl]pyridine-3-carboxamide;6-tert-butyl-2-[2-(hydroxymethyl)-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]phenyl]-3,4-dihydro-2,7-naphthyridin-1-one;2-(6-tert-butyl-1-oxo-3,4-dihydro-2,7-naphthyridin-2-yl)-6-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]benzaldehyde;6-tert-butylpyridine-3-carboxamide;2,6-dibromobenzaldehyde;2,2-dimethylpropanoic acid;3-(1,3-dioxoisoindol-2-yl)propanoic acid;pyridine-3-carboxamide (PubChem CID 159068578) has the molecular formula C176H190Br4N28O28 and a molecular weight of 3465.24 g/mol. Its IUPAC name is 2-bromo-6-(6-tert-butyl-1-oxo-3,4-dihydro-2,7-naphthyridin-2-yl)benzaldehyde;5-bromo-1-methyl-3-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]pyridin-2-one;6-tert-butyl-3,4-dihydro-2H-2,7-naphthyridin-1-one;6-tert-butyl-4-[2-(1,3-dioxoisoindol-2-yl)ethyl]pyridine-3-carboxamide;6-tert-butyl-2-[2-(hydroxymethyl)-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]phenyl]-3,4-dihydro-2,7-naphthyridin-1-one;2-(6-tert-butyl-1-oxo-3,4-dihydro-2,7-naphthyridin-2-yl)-6-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]benzaldehyde;6-tert-butylpyridine-3-carboxamide;2,6-dibromobenzaldehyde;2,2-dimethylpropanoic acid;3-(1,3-dioxoisoindol-2-yl)propanoic acid;pyridine-3-carboxamide.

Molecular Properties

Compound Name2-bromo-6-(6-tert-butyl-1-oxo-3,4-dihydro-2,7-naphthyridin-2-yl)benzaldehyde;5-bromo-1-methyl-3-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]pyridin-2-one;6-tert-butyl-3,4-dihydro-2H-2,7-naphthyridin-1-one;6-tert-butyl-4-[2-(1,3-dioxoisoindol-2-yl)ethyl]pyridine-3-carboxamide;6-tert-butyl-2-[2-(hydroxymethyl)-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]phenyl]-3,4-dihydro-2,7-naphthyridin-1-one;2-(6-tert-butyl-1-oxo-3,4-dihydro-2,7-naphthyridin-2-yl)-6-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]benzaldehyde;6-tert-butylpyridine-3-carboxamide;2,6-dibromobenzaldehyde;2,2-dimethylpropanoic acid;3-(1,3-dioxoisoindol-2-yl)propanoic acid;pyridine-3-carboxamide
PubChem CID159068578
Molecular FormulaC176H190Br4N28O28
Molecular Weight3465.24 g/mol
Exact Mass3459.10
IUPAC Name2-bromo-6-(6-tert-butyl-1-oxo-3,4-dihydro-2,7-naphthyridin-2-yl)benzaldehyde;5-bromo-1-methyl-3-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]pyridin-2-one;6-tert-butyl-3,4-dihydro-2H-2,7-naphthyridin-1-one;6-tert-butyl-4-[2-(1,3-dioxoisoindol-2-yl)ethyl]pyridine-3-carboxamide;6-tert-butyl-2-[2-(hydroxymethyl)-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]phenyl]-3,4-dihydro-2,7-naphthyridin-1-one;2-(6-tert-butyl-1-oxo-3,4-dihydro-2,7-naphthyridin-2-yl)-6-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]benzaldehyde;6-tert-butylpyridine-3-carboxamide;2,6-dibromobenzaldehyde;2,2-dimethylpropanoic acid;3-(1,3-dioxoisoindol-2-yl)propanoic acid;pyridine-3-carboxamide
SMILESCC(C)(C)C(=O)O.CC(C)(C)c1cc(CCN2C(=O)c3ccccc3C2=O)c(C(N)=O)cn1.CC(C)(C)c1cc2c(cn1)C(=O)N(c1cccc(Br)c1C=O)CC2.CC(C)(C)c1cc2c(cn1)C(=O)NCC2.CC(C)(C)c1ccc(C(N)=O)cn1.Cn1cc(-c2cccc(N3CCc4cc(C(C)(C)C)ncc4C3=O)c2C=O)cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c1=O.Cn1cc(-c2cccc(N3CCc4cc(C(C)(C)C)ncc4C3=O)c2CO)cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c1=O.Cn1cc(Br)cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c1=O.NC(=O)c1cccnc1.O=C(O)CCN1C(=O)c2ccccc2C1=O.O=Cc1c(Br)cccc1Br
InChIInChI=1S/C35H38N6O5.C35H36N6O5.C20H21N3O3.C19H19BrN2O2.C16H17BrN4O3.C12H16N2O.C11H9NO4.C10H14N2O.C7H4Br2O.C6H6N2O.C5H10O2/c2*1-35(2,3)30-17-22-10-11-41(33(44)26(22)19-36-30)29-7-5-6-25(27(29)21-42)24-16-28(34(45)39(4)20-24)38-31-9-8-23(18-37-31)32(43)40-12-14-46-15-13-40;1-20(2,3)16-10-12(15(11-22-16)17(21)24)8-9-23-18(25)13-6-4-5-7-14(13)19(23)26;1-19(2,3)17-9-12-7-8-22(18(24)13(12)10-21-17)16-6-4-5-15(20)14(16)11-23;1-20-10-12(17)8-13(16(20)23)19-14-3-2-11(9-18-14)15(22)21-4-6-24-7-5-21;1-12(2,3)10-6-8-4-5-13-11(15)9(8)7-14-10;13-9(14)5-6-12-10(15)7-3-1-2-4-8(7)11(12)16;1-10(2,3)8-5-4-7(6-12-8)9(11)13;8-6-2-1-3-7(9)5(6)4-10;7-6(9)5-2-1-3-8-4-5;1-5(2,3)4(6)7/h5-9,16-20,42H,10-15,21H2,1-4H3,(H,37,38);5-9,16-21H,10-15H2,1-4H3,(H,37,38);4-7,10-11H,8-9H2,1-3H3,(H2,21,24);4-6,9-11H,7-8H2,1-3H3;2-3,8-10H,4-7H2,1H3,(H,18,19);6-7H,4-5H2,1-3H3,(H,13,15);1-4H,5-6H2,(H,13,14);4-6H,1-3H3,(H2,11,13);1-4H;1-4H,(H2,7,9);1-3H3,(H,6,7)
InChIKeyJZIZCVHWRXXQBW-UHFFFAOYSA-N
XLogP24.88
TPSA759.71 Ų
H-Bond Donors10
H-Bond Acceptors42
Rotatable Bonds27
Heavy Atoms236
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003465.24
LogP ≤ 524.88
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1042

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze 2-bromo-6-(6-tert-butyl-1-oxo-3,4-dihydro-2,7-naphthyridin-2-yl)benzaldehyde;5-bromo-1-methyl-3-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]pyridin-2-one;6-tert-butyl-3,4-dihydro-2H-2,7-naphthyridin-1-one;6-tert-butyl-4-[2-(1,3-dioxoisoindol-2-yl)ethyl]pyridine-3-carboxamide;6-tert-butyl-2-[2-(hydroxymethyl)-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]phenyl]-3,4-dihydro-2,7-naphthyridin-1-one;2-(6-tert-butyl-1-oxo-3,4-dihydro-2,7-naphthyridin-2-yl)-6-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]benzaldehyde;6-tert-butylpyridine-3-carboxamide;2,6-dibromobenzaldehyde;2,2-dimethylpropanoic acid;3-(1,3-dioxoisoindol-2-yl)propanoic acid;pyridine-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-bromo-6-(6-tert-butyl-1-oxo-3,4-dihydro-2,7-naphthyridin-2-yl)benzaldehyde;5-bromo-1-methyl-3-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]pyridin-2-one;6-tert-butyl-3,4-dihydro-2H-2,7-naphthyridin-1-one;6-tert-butyl-4-[2-(1,3-dioxoisoindol-2-yl)ethyl]pyridine-3-carboxamide;6-tert-butyl-2-[2-(hydroxymethyl)-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]phenyl]-3,4-dihydro-2,7-naphthyridin-1-one;2-(6-tert-butyl-1-oxo-3,4-dihydro-2,7-naphthyridin-2-yl)-6-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]benzaldehyde;6-tert-butylpyridine-3-carboxamide;2,6-dibromobenzaldehyde;2,2-dimethylpropanoic acid;3-(1,3-dioxoisoindol-2-yl)propanoic acid;pyridine-3-carboxamide?
The IUPAC name of 2-bromo-6-(6-tert-butyl-1-oxo-3,4-dihydro-2,7-naphthyridin-2-yl)benzaldehyde;5-bromo-1-methyl-3-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]pyridin-2-one;6-tert-butyl-3,4-dihydro-2H-2,7-naphthyridin-1-one;6-tert-butyl-4-[2-(1,3-dioxoisoindol-2-yl)ethyl]pyridine-3-carboxamide;6-tert-butyl-2-[2-(hydroxymethyl)-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]phenyl]-3,4-dihydro-2,7-naphthyridin-1-one;2-(6-tert-butyl-1-oxo-3,4-dihydro-2,7-naphthyridin-2-yl)-6-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]benzaldehyde;6-tert-butylpyridine-3-carboxamide;2,6-dibromobenzaldehyde;2,2-dimethylpropanoic acid;3-(1,3-dioxoisoindol-2-yl)propanoic acid;pyridine-3-carboxamide (CID 159068578) is 2-bromo-6-(6-tert-butyl-1-oxo-3,4-dihydro-2,7-naphthyridin-2-yl)benzaldehyde;5-bromo-1-methyl-3-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]pyridin-2-one;6-tert-butyl-3,4-dihydro-2H-2,7-naphthyridin-1-one;6-tert-butyl-4-[2-(1,3-dioxoisoindol-2-yl)ethyl]pyridine-3-carboxamide;6-tert-butyl-2-[2-(hydroxymethyl)-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]phenyl]-3,4-dihydro-2,7-naphthyridin-1-one;2-(6-tert-butyl-1-oxo-3,4-dihydro-2,7-naphthyridin-2-yl)-6-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]benzaldehyde;6-tert-butylpyridine-3-carboxamide;2,6-dibromobenzaldehyde;2,2-dimethylpropanoic acid;3-(1,3-dioxoisoindol-2-yl)propanoic acid;pyridine-3-carboxamide.
What is the SMILES notation for 2-bromo-6-(6-tert-butyl-1-oxo-3,4-dihydro-2,7-naphthyridin-2-yl)benzaldehyde;5-bromo-1-methyl-3-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]pyridin-2-one;6-tert-butyl-3,4-dihydro-2H-2,7-naphthyridin-1-one;6-tert-butyl-4-[2-(1,3-dioxoisoindol-2-yl)ethyl]pyridine-3-carboxamide;6-tert-butyl-2-[2-(hydroxymethyl)-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]phenyl]-3,4-dihydro-2,7-naphthyridin-1-one;2-(6-tert-butyl-1-oxo-3,4-dihydro-2,7-naphthyridin-2-yl)-6-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]benzaldehyde;6-tert-butylpyridine-3-carboxamide;2,6-dibromobenzaldehyde;2,2-dimethylpropanoic acid;3-(1,3-dioxoisoindol-2-yl)propanoic acid;pyridine-3-carboxamide?
The canonical SMILES for 2-bromo-6-(6-tert-butyl-1-oxo-3,4-dihydro-2,7-naphthyridin-2-yl)benzaldehyde;5-bromo-1-methyl-3-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]pyridin-2-one;6-tert-butyl-3,4-dihydro-2H-2,7-naphthyridin-1-one;6-tert-butyl-4-[2-(1,3-dioxoisoindol-2-yl)ethyl]pyridine-3-carboxamide;6-tert-butyl-2-[2-(hydroxymethyl)-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]phenyl]-3,4-dihydro-2,7-naphthyridin-1-one;2-(6-tert-butyl-1-oxo-3,4-dihydro-2,7-naphthyridin-2-yl)-6-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]benzaldehyde;6-tert-butylpyridine-3-carboxamide;2,6-dibromobenzaldehyde;2,2-dimethylpropanoic acid;3-(1,3-dioxoisoindol-2-yl)propanoic acid;pyridine-3-carboxamide is CC(C)(C)C(=O)O.CC(C)(C)c1cc(CCN2C(=O)c3ccccc3C2=O)c(C(N)=O)cn1.CC(C)(C)c1cc2c(cn1)C(=O)N(c1cccc(Br)c1C=O)CC2.CC(C)(C)c1cc2c(cn1)C(=O)NCC2.CC(C)(C)c1ccc(C(N)=O)cn1.Cn1cc(-c2cccc(N3CCc4cc(C(C)(C)C)ncc4C3=O)c2C=O)cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c1=O.Cn1cc(-c2cccc(N3CCc4cc(C(C)(C)C)ncc4C3=O)c2CO)cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c1=O.Cn1cc(Br)cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c1=O.NC(=O)c1cccnc1.O=C(O)CCN1C(=O)c2ccccc2C1=O.O=Cc1c(Br)cccc1Br.
What is the InChIKey of 2-bromo-6-(6-tert-butyl-1-oxo-3,4-dihydro-2,7-naphthyridin-2-yl)benzaldehyde;5-bromo-1-methyl-3-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]pyridin-2-one;6-tert-butyl-3,4-dihydro-2H-2,7-naphthyridin-1-one;6-tert-butyl-4-[2-(1,3-dioxoisoindol-2-yl)ethyl]pyridine-3-carboxamide;6-tert-butyl-2-[2-(hydroxymethyl)-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]phenyl]-3,4-dihydro-2,7-naphthyridin-1-one;2-(6-tert-butyl-1-oxo-3,4-dihydro-2,7-naphthyridin-2-yl)-6-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]benzaldehyde;6-tert-butylpyridine-3-carboxamide;2,6-dibromobenzaldehyde;2,2-dimethylpropanoic acid;3-(1,3-dioxoisoindol-2-yl)propanoic acid;pyridine-3-carboxamide?
The InChIKey is JZIZCVHWRXXQBW-UHFFFAOYSA-N. The full InChI is InChI=1S/C35H38N6O5.C35H36N6O5.C20H21N3O3.C19H19BrN2O2.C16H17BrN4O3.C12H16N2O.C11H9NO4.C10H14N2O.C7H4Br2O.C6H6N2O.C5H10O2/c2*1-35(2,3)30-17-22-10-11-41(33(44)26(22)19-36-30)29-7-5-6-25(27(29)21-42)24-16-28(34(45)39(4)20-24)38-31-9-8-23(18-37-31)32(43)40-12-14-46-15-13-40;1-20(2,3)16-10-12(15(11-22-16)17(21)24)8-9-23-18(25)13-6-4-5-7-14(13)19(23)26;1-19(2,3)17-9-12-7-8-22(18(24)13(12)10-21-17)16-6-4-5-15(20)14(16)11-23;1-20-10-12(17)8-13(16(20)23)19-14-3-2-11(9-18-14)15(22)21-4-6-24-7-5-21;1-12(2,3)10-6-8-4-5-13-11(15)9(8)7-14-10;13-9(14)5-6-12-10(15)7-3-1-2-4-8(7)11(12)16;1-10(2,3)8-5-4-7(6-12-8)9(11)13;8-6-2-1-3-7(9)5(6)4-10;7-6(9)5-2-1-3-8-4-5;1-5(2,3)4(6)7/h5-9,16-20,42H,10-15,21H2,1-4H3,(H,37,38);5-9,16-21H,10-15H2,1-4H3,(H,37,38);4-7,10-11H,8-9H2,1-3H3,(H2,21,24);4-6,9-11H,7-8H2,1-3H3;2-3,8-10H,4-7H2,1H3,(H,18,19);6-7H,4-5H2,1-3H3,(H,13,15);1-4H,5-6H2,(H,13,14);4-6H,1-3H3,(H2,11,13);1-4H;1-4H,(H2,7,9);1-3H3,(H,6,7).
What are the key properties of 2-bromo-6-(6-tert-butyl-1-oxo-3,4-dihydro-2,7-naphthyridin-2-yl)benzaldehyde;5-bromo-1-methyl-3-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]pyridin-2-one;6-tert-butyl-3,4-dihydro-2H-2,7-naphthyridin-1-one;6-tert-butyl-4-[2-(1,3-dioxoisoindol-2-yl)ethyl]pyridine-3-carboxamide;6-tert-butyl-2-[2-(hydroxymethyl)-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]phenyl]-3,4-dihydro-2,7-naphthyridin-1-one;2-(6-tert-butyl-1-oxo-3,4-dihydro-2,7-naphthyridin-2-yl)-6-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]benzaldehyde;6-tert-butylpyridine-3-carboxamide;2,6-dibromobenzaldehyde;2,2-dimethylpropanoic acid;3-(1,3-dioxoisoindol-2-yl)propanoic acid;pyridine-3-carboxamide?
2-bromo-6-(6-tert-butyl-1-oxo-3,4-dihydro-2,7-naphthyridin-2-yl)benzaldehyde;5-bromo-1-methyl-3-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]pyridin-2-one;6-tert-butyl-3,4-dihydro-2H-2,7-naphthyridin-1-one;6-tert-butyl-4-[2-(1,3-dioxoisoindol-2-yl)ethyl]pyridine-3-carboxamide;6-tert-butyl-2-[2-(hydroxymethyl)-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]phenyl]-3,4-dihydro-2,7-naphthyridin-1-one;2-(6-tert-butyl-1-oxo-3,4-dihydro-2,7-naphthyridin-2-yl)-6-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]benzaldehyde;6-tert-butylpyridine-3-carboxamide;2,6-dibromobenzaldehyde;2,2-dimethylpropanoic acid;3-(1,3-dioxoisoindol-2-yl)propanoic acid;pyridine-3-carboxamide has a molecular weight of 3465.24 g/mol, XLogP of 24.88, 27 rotatable bonds, 10 hydrogen bond donors, and 42 hydrogen bond acceptors.
Where does this data come from?
All data for 2-bromo-6-(6-tert-butyl-1-oxo-3,4-dihydro-2,7-naphthyridin-2-yl)benzaldehyde;5-bromo-1-methyl-3-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]pyridin-2-one;6-tert-butyl-3,4-dihydro-2H-2,7-naphthyridin-1-one;6-tert-butyl-4-[2-(1,3-dioxoisoindol-2-yl)ethyl]pyridine-3-carboxamide;6-tert-butyl-2-[2-(hydroxymethyl)-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]phenyl]-3,4-dihydro-2,7-naphthyridin-1-one;2-(6-tert-butyl-1-oxo-3,4-dihydro-2,7-naphthyridin-2-yl)-6-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridinyl]amino]-6-oxo-3-pyridinyl]benzaldehyde;6-tert-butylpyridine-3-carboxamide;2,6-dibromobenzaldehyde;2,2-dimethylpropanoic acid;3-(1,3-dioxoisoindol-2-yl)propanoic acid;pyridine-3-carboxamide is sourced from PubChem (CID 159068578), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).